Qualis Innovations Inc QLIS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.27
- Day Range
- $0.31–0.32
- 52-Week Range
- $0.14–1.01
- Bid/Ask
- $0.26 / $0.99
- Market Cap
- $2.71 Mil
- Volume/Avg
- 200 / 228
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality-agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
Valuation
|
Metric
|
QLIS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
QLIS
Financial Strength
|
Metric
|
QLIS
|
|---|---|
Quick Ratio | 0.06 |
Current Ratio | 4.07 |
Interest Coverage | — |
Quick Ratio
QLIS
Profitability
|
Metric
|
QLIS
|
|---|---|
Return on Assets (Normalized) | 553.05% |
Return on Equity (Normalized) | 678.05% |
Return on Invested Capital (Normalized) | 619.07% |
Return on Assets
QLIS
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Mpszkxxg | Hcvmlmk | $185.8 Bil | |
SYK
| Stryker Corp | Tbwhcwrcn | Xwdxk | $124.7 Bil | |
MDT
| Medtronic PLC | Gzvtcdc | Hvgkn | $105.2 Bil | |
BSX
| Boston Scientific Corp | Zjwzqfxsy | Wflrpt | $99.0 Bil | |
EW
| Edwards Lifesciences Corp | Dgcvdkgff | Lrrgxsh | $52.3 Bil | |
DXCM
| DexCom Inc | Kgfdcfyw | Ynvl | $52.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wfscqtvf | Pnkrt | $24.8 Bil | |
ALGN
| Align Technology Inc | Dqdjmrcbb | Ktlxnw | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Mbnvgzjb | Hpvfby | $18.5 Bil | |
PODD
| Insulet Corp | Hnsnftjw | Hrpxrj | $11.5 Bil |